HEADER VIRAL PROTEIN/IMMUNE SYSTEM 28-DEC-20 7L7D TITLE CRYSTAL STRUCTURE OF SARS-COV-2 SPIKE RBD IN COMPLEX WITH HUMAN TITLE 2 MONOCLONAL ANTIBODY AZD8895 COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEAVY CHAIN OF HUMAN MONOCLONAL ANTIBODY FAB AZD8895; COMPND 3 CHAIN: H; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: LIGHT CHAIN OF HUMAN MONOCLONAL ANTIBODY FAB AZD8895; COMPND 7 CHAIN: L; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 3; COMPND 10 MOLECULE: SPIKE PROTEIN S1; COMPND 11 CHAIN: E; COMPND 12 FRAGMENT: RECEPTOR BINDING DOMAIN (UNP RESIDUES 330-529); COMPND 13 SYNONYM: S GLYCOPROTEIN,E2,PEPLOMER PROTEIN,SPIKE GLYCOPROTEIN; COMPND 14 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 6 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 13 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 15 MOL_ID: 3; SOURCE 16 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS SOURCE 17 2; SOURCE 18 ORGANISM_COMMON: 2019-NCOV; SOURCE 19 ORGANISM_TAXID: 2697049; SOURCE 20 GENE: S, 2; SOURCE 21 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 22 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 23 EXPRESSION_SYSTEM_TAXID: 9606 KEYWDS SARS-COV-2, SPIKE PROTEIN, RECEPTOR BINDING DOMAIN, HUMAN MONOCLONAL KEYWDS 2 ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.DONG,J.E.CROWE REVDAT 3 18-OCT-23 7L7D 1 REMARK REVDAT 2 16-MAR-22 7L7D 1 JRNL REVDAT 1 01-SEP-21 7L7D 0 JRNL AUTH J.DONG,S.J.ZOST,A.J.GREANEY,T.N.STARR,A.S.DINGENS,E.C.CHEN, JRNL AUTH 2 R.E.CHEN,J.B.CASE,R.E.SUTTON,P.GILCHUK,J.RODRIGUEZ, JRNL AUTH 3 E.ARMSTRONG,C.GAINZA,R.S.NARGI,E.BINSHTEIN,X.XIE,X.ZHANG, JRNL AUTH 4 P.Y.SHI,J.LOGUE,S.WESTON,M.E.MCGRATH,M.B.FRIEMAN,T.BRADY, JRNL AUTH 5 K.M.TUFFY,H.BRIGHT,Y.M.LOO,P.M.MCTAMNEY,M.T.ESSER, JRNL AUTH 6 R.H.CARNAHAN,M.S.DIAMOND,J.D.BLOOM,J.E.CROWE JR. JRNL TITL GENETIC AND STRUCTURAL BASIS FOR SARS-COV-2 VARIANT JRNL TITL 2 NEUTRALIZATION BY A TWO-ANTIBODY COCKTAIL. JRNL REF NAT MICROBIOL V. 6 1233 2021 JRNL REFN ESSN 2058-5276 JRNL PMID 34548634 JRNL DOI 10.1038/S41564-021-00972-2 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.17.1_3660: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 43.98 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 24875 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.187 REMARK 3 R VALUE (WORKING SET) : 0.185 REMARK 3 FREE R VALUE : 0.231 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.950 REMARK 3 FREE R VALUE TEST SET COUNT : 1232 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 43.9800 - 5.2000 1.00 2684 148 0.1649 0.2048 REMARK 3 2 5.1900 - 4.1300 1.00 2643 137 0.1366 0.1813 REMARK 3 3 4.1300 - 3.6000 1.00 2638 132 0.1678 0.2092 REMARK 3 4 3.6000 - 3.2700 1.00 2642 133 0.1870 0.2292 REMARK 3 5 3.2700 - 3.0400 1.00 2608 152 0.2159 0.2677 REMARK 3 6 3.0400 - 2.8600 1.00 2602 135 0.2240 0.2695 REMARK 3 7 2.8600 - 2.7200 1.00 2600 144 0.2383 0.2728 REMARK 3 8 2.7200 - 2.6000 1.00 2583 145 0.2578 0.3404 REMARK 3 9 2.6000 - 2.5000 0.99 2643 106 0.2506 0.3152 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.290 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 24.090 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.003 4955 REMARK 3 ANGLE : 0.563 6730 REMARK 3 CHIRALITY : 0.043 737 REMARK 3 PLANARITY : 0.004 869 REMARK 3 DIHEDRAL : 16.304 703 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): -17.4857 15.6466 53.4486 REMARK 3 T TENSOR REMARK 3 T11: 0.1859 T22: 0.2393 REMARK 3 T33: 0.3286 T12: -0.0393 REMARK 3 T13: -0.0557 T23: 0.0642 REMARK 3 L TENSOR REMARK 3 L11: 0.8354 L22: 0.6809 REMARK 3 L33: 1.3552 L12: -0.5098 REMARK 3 L13: -0.5137 L23: 0.7017 REMARK 3 S TENSOR REMARK 3 S11: -0.0049 S12: -0.0451 S13: -0.0546 REMARK 3 S21: 0.0382 S22: -0.0038 S23: 0.0112 REMARK 3 S31: 0.0451 S32: -0.1573 S33: 0.0167 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7L7D COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 29-DEC-20. REMARK 100 THE DEPOSITION ID IS D_1000253830. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 17-SEP-20 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 21-ID-F REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97872 REMARK 200 MONOCHROMATOR : DIAMOND(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX-300 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 24896 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 43.980 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 3.700 REMARK 200 R MERGE (I) : 0.04600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 19.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.63 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.24500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 6XC2 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.19 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.63 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 16% PEG3350, 0.2 M TRIS-HCL, PH 8.5, REMARK 280 VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 40.79150 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6330 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 28300 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -28.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: H, L, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 UNK H 138 REMARK 465 UNK H 139 REMARK 465 UNK H 140 REMARK 465 UNK H 141 REMARK 465 UNK H 142 REMARK 465 UNK H 143 REMARK 465 CYS H 226 REMARK 465 CYS L 216 REMARK 465 PRO E 330 REMARK 465 ASN E 331 REMARK 465 ILE E 332 REMARK 465 THR E 333 REMARK 465 GLY E 530 REMARK 465 LEU E 531 REMARK 465 VAL E 532 REMARK 465 PRO E 533 REMARK 465 ARG E 534 REMARK 465 GLY E 535 REMARK 465 SER E 536 REMARK 465 HIS E 537 REMARK 465 HIS E 538 REMARK 465 HIS E 539 REMARK 465 HIS E 540 REMARK 465 HIS E 541 REMARK 465 HIS E 542 REMARK 465 HIS E 543 REMARK 465 HIS E 544 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN H 1 CG CD OE1 NE2 REMARK 470 MET H 30 CG SD CE REMARK 470 SER H 137 OG REMARK 470 THR H 201 OG1 CG2 REMARK 470 LYS H 220 CE NZ REMARK 470 LYS L 171 CG CD CE NZ REMARK 470 LYS L 192 CG CD CE NZ REMARK 470 SER E 359 OG REMARK 470 VAL E 362 CG1 CG2 REMARK 470 ASP E 364 CG OD1 OD2 REMARK 470 VAL E 367 CG1 CG2 REMARK 470 SER E 373 OG REMARK 470 SER E 383 OG REMARK 470 THR E 393 OG1 CG2 REMARK 470 SER E 438 OG REMARK 470 LYS E 444 CG CD CE NZ REMARK 470 VAL E 445 CG1 CG2 REMARK 470 THR E 500 OG1 CG2 REMARK 470 VAL E 503 CG1 CG2 REMARK 470 LEU E 517 CG CD1 CD2 REMARK 470 LEU E 518 CG CD1 CD2 REMARK 470 HIS E 519 CG ND1 CD2 CE1 NE2 REMARK 470 THR E 523 OG1 CG2 REMARK 470 VAL E 524 CG1 CG2 REMARK 470 LYS E 528 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 MET H 2 76.38 59.60 REMARK 500 ARG H 67 15.28 -147.92 REMARK 500 SER H 102 -165.30 -107.21 REMARK 500 ASP H 108 30.27 -96.05 REMARK 500 ASP H 154 62.42 63.06 REMARK 500 ALA L 52 -35.66 69.80 REMARK 500 SER L 94 -160.72 58.00 REMARK 500 ASN L 140 71.85 54.86 REMARK 500 ALA E 352 49.94 -109.01 REMARK 500 SER E 359 -68.23 -94.38 REMARK 500 CYS E 361 -171.03 -175.47 REMARK 500 PHE E 377 69.98 -151.83 REMARK 500 ASN E 422 -65.98 -122.58 REMARK 500 ASP E 428 41.27 -93.01 REMARK 500 ASP E 442 38.00 -88.50 REMARK 500 LEU E 518 -159.54 -125.13 REMARK 500 THR E 523 -51.37 -144.32 REMARK 500 REMARK 500 REMARK: NULL DBREF 7L7D H 1 226 PDB 7L7D 7L7D 1 226 DBREF 7L7D L 1 216 PDB 7L7D 7L7D 1 216 DBREF 7L7D E 330 529 UNP P0DTC2 SPIKE_SARS2 330 529 SEQADV 7L7D GLY E 530 UNP P0DTC2 EXPRESSION TAG SEQADV 7L7D LEU E 531 UNP P0DTC2 EXPRESSION TAG SEQADV 7L7D VAL E 532 UNP P0DTC2 EXPRESSION TAG SEQADV 7L7D PRO E 533 UNP P0DTC2 EXPRESSION TAG SEQADV 7L7D ARG E 534 UNP P0DTC2 EXPRESSION TAG SEQADV 7L7D GLY E 535 UNP P0DTC2 EXPRESSION TAG SEQADV 7L7D SER E 536 UNP P0DTC2 EXPRESSION TAG SEQADV 7L7D HIS E 537 UNP P0DTC2 EXPRESSION TAG SEQADV 7L7D HIS E 538 UNP P0DTC2 EXPRESSION TAG SEQADV 7L7D HIS E 539 UNP P0DTC2 EXPRESSION TAG SEQADV 7L7D HIS E 540 UNP P0DTC2 EXPRESSION TAG SEQADV 7L7D HIS E 541 UNP P0DTC2 EXPRESSION TAG SEQADV 7L7D HIS E 542 UNP P0DTC2 EXPRESSION TAG SEQADV 7L7D HIS E 543 UNP P0DTC2 EXPRESSION TAG SEQADV 7L7D HIS E 544 UNP P0DTC2 EXPRESSION TAG SEQRES 1 H 226 GLN MET GLN LEU VAL GLN SER GLY PRO GLU VAL LYS LYS SEQRES 2 H 226 PRO GLY THR SER VAL LYS VAL SER CYS LYS ALA SER GLY SEQRES 3 H 226 PHE THR PHE MET SER SER ALA VAL GLN TRP VAL ARG GLN SEQRES 4 H 226 ALA ARG GLY GLN ARG LEU GLU TRP ILE GLY TRP ILE VAL SEQRES 5 H 226 ILE GLY SER GLY ASN THR ASN TYR ALA GLN LYS PHE GLN SEQRES 6 H 226 GLU ARG VAL THR ILE THR ARG ASP MET SER THR SER THR SEQRES 7 H 226 ALA TYR MET GLU LEU SER SER LEU ARG SER GLU ASP THR SEQRES 8 H 226 ALA VAL TYR TYR CYS ALA ALA PRO TYR CYS SER SER ILE SEQRES 9 H 226 SER CYS ASN ASP GLY PHE ASP ILE TRP GLY GLN GLY THR SEQRES 10 H 226 MET VAL THR VAL SER SER ALA SER THR LYS GLY PRO SER SEQRES 11 H 226 VAL PHE PRO LEU ALA PRO SER UNK UNK UNK UNK UNK UNK SEQRES 12 H 226 GLY THR ALA ALA LEU GLY CYS LEU VAL LYS ASP TYR PHE SEQRES 13 H 226 PRO GLU PRO VAL THR VAL SER TRP ASN SER GLY ALA LEU SEQRES 14 H 226 THR SER GLY VAL HIS THR PHE PRO ALA VAL LEU GLN SER SEQRES 15 H 226 SER GLY LEU TYR SER LEU SER SER VAL VAL THR VAL PRO SEQRES 16 H 226 SER SER SER LEU GLY THR GLN THR TYR ILE CYS ASN VAL SEQRES 17 H 226 ASN HIS LYS PRO SER ASN THR LYS VAL ASP LYS LYS VAL SEQRES 18 H 226 GLU PRO LYS SER CYS SEQRES 1 L 216 GLU ILE VAL LEU THR GLN SER PRO GLY THR LEU SER LEU SEQRES 2 L 216 SER PRO GLY GLU ARG ALA THR LEU SER CYS ARG ALA SER SEQRES 3 L 216 GLN SER VAL SER SER SER TYR LEU ALA TRP TYR GLN GLN SEQRES 4 L 216 LYS PRO GLY GLN ALA PRO ARG LEU LEU ILE TYR GLY ALA SEQRES 5 L 216 SER SER ARG ALA THR GLY ILE PRO ASP ARG PHE SER GLY SEQRES 6 L 216 SER GLY SER GLY THR ASP PHE THR LEU THR ILE SER ARG SEQRES 7 L 216 LEU GLU PRO GLU ASP PHE ALA VAL TYR TYR CYS GLN HIS SEQRES 8 L 216 TYR GLY SER SER ARG GLY TRP THR PHE GLY GLN GLY THR SEQRES 9 L 216 LYS VAL GLU ILE LYS ARG THR VAL ALA ALA PRO SER VAL SEQRES 10 L 216 PHE ILE PHE PRO PRO SER ASP GLU GLN LEU LYS SER GLY SEQRES 11 L 216 THR ALA SER VAL VAL CYS LEU LEU ASN ASN PHE TYR PRO SEQRES 12 L 216 ARG GLU ALA LYS VAL GLN TRP LYS VAL ASP ASN ALA LEU SEQRES 13 L 216 GLN SER GLY ASN SER GLN GLU SER VAL THR GLU GLN ASP SEQRES 14 L 216 SER LYS ASP SER THR TYR SER LEU SER SER THR LEU THR SEQRES 15 L 216 LEU SER LYS ALA ASP TYR GLU LYS HIS LYS VAL TYR ALA SEQRES 16 L 216 CYS GLU VAL THR HIS GLN GLY LEU ARG SER PRO VAL THR SEQRES 17 L 216 LYS SER PHE ASN ARG GLY GLU CYS SEQRES 1 E 215 PRO ASN ILE THR ASN LEU CYS PRO PHE GLY GLU VAL PHE SEQRES 2 E 215 ASN ALA THR ARG PHE ALA SER VAL TYR ALA TRP ASN ARG SEQRES 3 E 215 LYS ARG ILE SER ASN CYS VAL ALA ASP TYR SER VAL LEU SEQRES 4 E 215 TYR ASN SER ALA SER PHE SER THR PHE LYS CYS TYR GLY SEQRES 5 E 215 VAL SER PRO THR LYS LEU ASN ASP LEU CYS PHE THR ASN SEQRES 6 E 215 VAL TYR ALA ASP SER PHE VAL ILE ARG GLY ASP GLU VAL SEQRES 7 E 215 ARG GLN ILE ALA PRO GLY GLN THR GLY LYS ILE ALA ASP SEQRES 8 E 215 TYR ASN TYR LYS LEU PRO ASP ASP PHE THR GLY CYS VAL SEQRES 9 E 215 ILE ALA TRP ASN SER ASN ASN LEU ASP SER LYS VAL GLY SEQRES 10 E 215 GLY ASN TYR ASN TYR LEU TYR ARG LEU PHE ARG LYS SER SEQRES 11 E 215 ASN LEU LYS PRO PHE GLU ARG ASP ILE SER THR GLU ILE SEQRES 12 E 215 TYR GLN ALA GLY SER THR PRO CYS ASN GLY VAL GLU GLY SEQRES 13 E 215 PHE ASN CYS TYR PHE PRO LEU GLN SER TYR GLY PHE GLN SEQRES 14 E 215 PRO THR ASN GLY VAL GLY TYR GLN PRO TYR ARG VAL VAL SEQRES 15 E 215 VAL LEU SER PHE GLU LEU LEU HIS ALA PRO ALA THR VAL SEQRES 16 E 215 CYS GLY PRO LYS LYS GLY LEU VAL PRO ARG GLY SER HIS SEQRES 17 E 215 HIS HIS HIS HIS HIS HIS HIS HET GOL H 301 6 HET GOL H 302 6 HET GOL L 301 6 HET GOL L 302 6 HET NAG E 601 14 HET GOL E 602 6 HET GOL E 603 6 HETNAM GOL GLYCEROL HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 4 GOL 6(C3 H8 O3) FORMUL 8 NAG C8 H15 N O6 FORMUL 11 HOH *219(H2 O) HELIX 1 AA1 THR H 28 SER H 31 5 4 HELIX 2 AA2 GLN H 62 GLN H 65 5 4 HELIX 3 AA3 ARG H 87 THR H 91 5 5 HELIX 4 AA4 SER H 166 ALA H 168 5 3 HELIX 5 AA5 SER H 197 LEU H 199 5 3 HELIX 6 AA6 SER L 30 SER L 32 5 3 HELIX 7 AA7 GLU L 80 PHE L 84 5 5 HELIX 8 AA8 SER L 123 SER L 129 1 7 HELIX 9 AA9 LYS L 185 GLU L 189 1 5 HELIX 10 AB1 PRO E 337 ASN E 343 1 7 HELIX 11 AB2 SER E 349 TRP E 353 5 5 HELIX 12 AB3 ASP E 364 ASN E 370 1 7 HELIX 13 AB4 THR E 385 ASP E 389 5 5 HELIX 14 AB5 ASP E 405 ILE E 410 5 6 HELIX 15 AB6 GLY E 416 ASN E 422 1 7 HELIX 16 AB7 GLY E 502 TYR E 505 5 4 SHEET 1 AA1 4 GLN H 3 GLN H 6 0 SHEET 2 AA1 4 VAL H 18 SER H 25 -1 O LYS H 23 N VAL H 5 SHEET 3 AA1 4 THR H 78 LEU H 83 -1 O ALA H 79 N CYS H 22 SHEET 4 AA1 4 VAL H 68 ASP H 73 -1 N THR H 69 O GLU H 82 SHEET 1 AA2 6 GLU H 10 LYS H 12 0 SHEET 2 AA2 6 THR H 117 VAL H 121 1 O THR H 120 N GLU H 10 SHEET 3 AA2 6 ALA H 92 ALA H 98 -1 N TYR H 94 O THR H 117 SHEET 4 AA2 6 ALA H 33 GLN H 39 -1 N VAL H 37 O TYR H 95 SHEET 5 AA2 6 GLU H 46 VAL H 52 -1 O GLY H 49 N TRP H 36 SHEET 6 AA2 6 THR H 58 TYR H 60 -1 O ASN H 59 N TRP H 50 SHEET 1 AA3 4 GLU H 10 LYS H 12 0 SHEET 2 AA3 4 THR H 117 VAL H 121 1 O THR H 120 N GLU H 10 SHEET 3 AA3 4 ALA H 92 ALA H 98 -1 N TYR H 94 O THR H 117 SHEET 4 AA3 4 ILE H 112 TRP H 113 -1 O ILE H 112 N ALA H 98 SHEET 1 AA4 4 SER H 130 LEU H 134 0 SHEET 2 AA4 4 THR H 145 TYR H 155 -1 O LEU H 151 N PHE H 132 SHEET 3 AA4 4 TYR H 186 PRO H 195 -1 O VAL H 194 N ALA H 146 SHEET 4 AA4 4 VAL H 173 THR H 175 -1 N HIS H 174 O VAL H 191 SHEET 1 AA5 4 SER H 130 LEU H 134 0 SHEET 2 AA5 4 THR H 145 TYR H 155 -1 O LEU H 151 N PHE H 132 SHEET 3 AA5 4 TYR H 186 PRO H 195 -1 O VAL H 194 N ALA H 146 SHEET 4 AA5 4 VAL H 179 LEU H 180 -1 N VAL H 179 O SER H 187 SHEET 1 AA6 3 THR H 161 TRP H 164 0 SHEET 2 AA6 3 ILE H 205 HIS H 210 -1 O ASN H 207 N SER H 163 SHEET 3 AA6 3 THR H 215 LYS H 220 -1 O THR H 215 N HIS H 210 SHEET 1 AA7 4 LEU L 4 SER L 7 0 SHEET 2 AA7 4 ALA L 19 ALA L 25 -1 O ARG L 24 N THR L 5 SHEET 3 AA7 4 ASP L 71 ILE L 76 -1 O LEU L 74 N LEU L 21 SHEET 4 AA7 4 PHE L 63 SER L 68 -1 N SER L 64 O THR L 75 SHEET 1 AA8 6 THR L 10 LEU L 13 0 SHEET 2 AA8 6 THR L 104 ILE L 108 1 O LYS L 105 N LEU L 11 SHEET 3 AA8 6 VAL L 86 HIS L 91 -1 N TYR L 87 O THR L 104 SHEET 4 AA8 6 LEU L 34 GLN L 39 -1 N TYR L 37 O TYR L 88 SHEET 5 AA8 6 ARG L 46 TYR L 50 -1 O LEU L 48 N TRP L 36 SHEET 6 AA8 6 SER L 54 ARG L 55 -1 O SER L 54 N TYR L 50 SHEET 1 AA9 4 THR L 10 LEU L 13 0 SHEET 2 AA9 4 THR L 104 ILE L 108 1 O LYS L 105 N LEU L 11 SHEET 3 AA9 4 VAL L 86 HIS L 91 -1 N TYR L 87 O THR L 104 SHEET 4 AA9 4 THR L 99 PHE L 100 -1 O THR L 99 N HIS L 91 SHEET 1 AB1 4 SER L 116 PHE L 120 0 SHEET 2 AB1 4 THR L 131 PHE L 141 -1 O VAL L 135 N PHE L 120 SHEET 3 AB1 4 TYR L 175 SER L 184 -1 O LEU L 181 N VAL L 134 SHEET 4 AB1 4 SER L 161 VAL L 165 -1 N SER L 164 O SER L 178 SHEET 1 AB2 4 ALA L 155 GLN L 157 0 SHEET 2 AB2 4 LYS L 147 VAL L 152 -1 N TRP L 150 O GLN L 157 SHEET 3 AB2 4 VAL L 193 THR L 199 -1 O ALA L 195 N LYS L 151 SHEET 4 AB2 4 VAL L 207 ASN L 212 -1 O LYS L 209 N CYS L 196 SHEET 1 AB3 5 ASN E 354 ILE E 358 0 SHEET 2 AB3 5 ASN E 394 ARG E 403 -1 O VAL E 395 N ILE E 358 SHEET 3 AB3 5 PRO E 507 GLU E 516 -1 O TYR E 508 N ILE E 402 SHEET 4 AB3 5 GLY E 431 ASN E 437 -1 N ILE E 434 O VAL E 511 SHEET 5 AB3 5 THR E 376 TYR E 380 -1 N LYS E 378 O VAL E 433 SHEET 1 AB4 3 CYS E 361 VAL E 362 0 SHEET 2 AB4 3 VAL E 524 CYS E 525 1 O CYS E 525 N CYS E 361 SHEET 3 AB4 3 CYS E 391 PHE E 392 -1 N PHE E 392 O VAL E 524 SHEET 1 AB5 2 LEU E 452 ARG E 454 0 SHEET 2 AB5 2 LEU E 492 SER E 494 -1 O GLN E 493 N TYR E 453 SHEET 1 AB6 2 TYR E 473 GLN E 474 0 SHEET 2 AB6 2 CYS E 488 TYR E 489 -1 O TYR E 489 N TYR E 473 SSBOND 1 CYS H 22 CYS H 96 1555 1555 2.04 SSBOND 2 CYS H 101 CYS H 106 1555 1555 2.03 SSBOND 3 CYS H 150 CYS H 206 1555 1555 2.03 SSBOND 4 CYS L 23 CYS L 89 1555 1555 2.05 SSBOND 5 CYS L 136 CYS L 196 1555 1555 2.03 SSBOND 6 CYS E 336 CYS E 361 1555 1555 2.04 SSBOND 7 CYS E 379 CYS E 432 1555 1555 2.04 SSBOND 8 CYS E 391 CYS E 525 1555 1555 2.05 SSBOND 9 CYS E 480 CYS E 488 1555 1555 2.03 LINK ND2 ASN E 343 C1 NAG E 601 1555 1555 1.44 CISPEP 1 PHE H 156 PRO H 157 0 -2.53 CISPEP 2 GLU H 158 PRO H 159 0 -2.15 CISPEP 3 SER L 7 PRO L 8 0 -2.68 CISPEP 4 TYR L 142 PRO L 143 0 1.70 CRYST1 44.118 81.583 101.157 90.00 94.60 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.022666 0.000000 0.001823 0.00000 SCALE2 0.000000 0.012257 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009918 0.00000